Skip to Content

MainStay WMC Value A MAPAX

Medalist Rating as of | See New York Life Investment Hub
  • NAV / 1-Day Return 27.85  /  +0.14 %
  • Total Assets 948.3 Mil
  • Adj. Expense Ratio
    1.040%
  • Expense Ratio 1.040%
  • Distribution Fee Level Average
  • Share Class Type Front Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 15,000
  • Status Open
  • TTM Yield 1.31%
  • Turnover 29%

USD | NAV as of Apr 18, 2024 | 1-Day Return as of Apr 18, 2024, 10:09 PM GMT+0

Morningstar’s Analysis MAPAX

Will MAPAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The combination of an Average People Pillar rating and a Below Average Process Pillar rating limit MainStay WMC Value A to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MAPAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

JPMorgan Chase & Co

3.98 38.8 Mil
Financial Services

Johnson & Johnson

3.10 30.2 Mil
Healthcare

Merck & Co Inc

3.01 29.3 Mil
Healthcare

Cisco Systems Inc

2.50 24.4 Mil
Technology

Elevance Health Inc

2.13 20.7 Mil
Healthcare

Pfizer Inc

2.08 20.2 Mil
Healthcare

ConocoPhillips

1.98 19.3 Mil
Energy

M&T Bank Corp

1.92 18.7 Mil
Financial Services

American International Group Inc

1.90 18.5 Mil
Financial Services

UnitedHealth Group Inc

1.87 18.2 Mil
Healthcare